Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
08 February 2023
Closing Date:
30 December 2024
Location(s):
DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
Description:
Non-exclusive agreements are being sought for the supply of contrast agents for various applications, including CT, MRI, and ultrasound, with specific requirements for active ingredients, dosage forms, concentrations, and pack sizes. Further details can be found in Appendix 5 to the request for quotation.
Contrast agent - Cross-active ingredient open-house process for the CT region Schleswig-Holstein

The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent active ingredients/active ingredient combinations within the framework of an open-house procedure, which are prescribed and dispensed at the expense of the health insurance funds in Schleswig-Holstein in the SSB. Further details on the active substances concerned can be found in the section classification (Annex 5 to this publication). Contrast agents of each future contractual partner can be ordered by the panel physicians who are informed about these economic sources of supply during the term of the contract on the basis of the economic efficiency requirement; They are considered economical. Contract physicians are obliged to meet their need for contrast agents from a specialist group with the products of the contractual partner or one of the contractual partners. For each specialist group, there is a fixed contract price that is non-negotiable for the duration of the contract.

Section E

Description: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media

Application: intrathecal. More possible.

Application areas:

- cervical, thoracic and lumbar myelography and radioculography

- CT myelography

Active ingredients / combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible

Dosage forms: all approved dosage forms of an active substance must be offered

Concentration: 200 mg/ml - 300 mg/ml, all concentrations of an active substance must be offered

Pack size: all approved pack sizes of an active substance must be offered.

Further information can be found in Appendix 5 to the request for quotation.

Section R

Name: ultrasound contrast medium

Application: Intravenous use

Areas of application: echocardiography, others possible

Active ingredients / combinations (ATC): Albumin microspheres, containing perflutren (V08DA01)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section S

Name: ultrasound contrast medium

Application: Intravenous use

Areas of application: echocardiography, Doppler sonography (macro and microvasculature), ultrasound of the lower urinary tract

Active ingredients / combinations (ATC): Sulfur hexafluoride (V08DA05)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section T

Name: Superparamagnetic MRI contrast agent (iron oxide)

Application: Intravenous use

Indications: MRI of the liver

Active substances/combinations (ATC): Ferucarbotran (V08CB03)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section G

Description: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media

Application: intra-arterial and intravenous and intracavity. More possible.

Application areas:

- urography,

- phlebography,

- CT contrast enhancement

- digital subtraction angiography (DSA)

Active ingredients / combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible

Dosage forms: all approved dosage forms of an active substance must be offered

Concentration: 150 mg/ml - 250 mg/ml, all concentrations of an active substance must be offered

Pack size: all approved pack sizes of an active substance must be offered.

Further information can be found in Appendix 5 to the request for quotation.

Section H

Description: Non-ionic iodine-containing dimeric, low-osmolar, water-soluble nephrotropic X-ray contrast media.

Application: intra-arterial and intravenous. More possible.

Application areas:

- cerebral angiography, abdominal angiography, peripheral arteriography, venography,

- urography,

- Contrast enhancement in computed tomography (CT).

Active ingredients / combinations (ATC): Iodixanol (V08AB09) and / or others possible.

Dosage forms: all approved dosage forms of an active ingredient must be offered.

Concentrations must be offered cumulatively:

1. 270 mg/ml (all concentrations of an active substance must be offered)

2. 320 mg/ml (all concentrations of an active substance must be offered)

(at least all areas of application must be covered together).

Pack size: all approved pack sizes of an active substance must be offered.

Further information can be found in Appendix 5 to the request for quotation.

Section J

Name: Paramagnetic extracellular linear contrast media for MRI.

Application: Intra-articular application.

Areas of application: Direct magnetic resonance arthrography.

NSF risk: high NSF risk class.

Active ingredients / combinations (ATC): gadopentetic acid (V08CA01).

Dosage forms: All dosage forms of the active ingredient for this indication.

Concentration: 0.002 mmol / ml.

Pack size: All pack sizes of the active ingredient for this indication.

Further information can be found in Appendix 5 to the request for quotation.

Section M

Name: Paramagnetic extracellular macrocyclic contrast media for MRI.

Application: Intra-articular application.

Areas of application: Direct magnetic resonance arthrography.

NSF risk: Low NSF risk class.

Active ingredients / combinations (ATC): Gadoteric acid (V08CA02).

Dosage forms: All dosage forms of the active ingredient for this indication.

Concentration: 0.0025 mmol / ml.

Pack size: All pack sizes of the active ingredient for this indication.

Further information can be found in Appendix 5 to the request for quotation.

Section N

Name: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion.

Application: Intravenous. More possible.

Areas of application: MRI of the liver.

NSF risk: Medium NSF risk class.

Active ingredients / combinations (ATC): gadobenic acid (V08CA08).

Dosage forms: All approved dosage forms of an active ingredient.

Concentration: All concentrations possible.

Pack size: All approved pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section O

Designation: Paramagnetic combines extracellular and hepatobiliary linear contrast agents for MRI (excretion 50-50).

Application: Intravenous use. More possible.

Areas of application: MRI of the liver.

NSF risk: Medium NSF risk class.

Active ingredients / combinations (ATC): Gadoxetic acid (V08CA10).

Dosage forms: All dosage forms of the active ingredient.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section P

Description: Contrast media containing barium sulphate.

Application: Oral and / or intestinal and / or rectal use.

Areas of application: Representation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, others are possible.

Active ingredients / combinations (ATC): Barium sulfate (V08BA).

Dosage forms: All dosage forms of the active ingredient.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section Q

Name :Ultrasonic Contrast Agent

Application: Intravenous use

Areas of application: echocardiography, others possible

Active ingredients / combinations (ATC): Phospholipid microspheres, containing perflutren (V08DA04)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: all pack sizes of the active ingredient

Further information can be found in Appendix 5 to the request for quotation

Download full details as .pdf
The Buyer:
Der AOK-Bundesverband führt im Namen der in der Bekanntmachung genannten Auftraggeberinnen das Vergabeverfahren durch.
CPV Code(s):
33600000 - Pharmaceutical products
33696000 - Reagents and contrast media
33696800 - X-ray contrast media